🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 14 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/02/2002 | 6,00 | 6,35 | 5,98 | 6,35 | +4,10% | 6,17% | 350.600 |
| 27/02/2002 | 6,05 | 6,10 | 5,92 | 6,10 | +0,83% | 2,98% | 209.600 |
| 26/02/2002 | 5,92 | 6,11 | 5,85 | 6,05 | +3,77% | 4,31% | 340.200 |
| 25/02/2002 | 5,63 | 6,03 | 5,53 | 5,83 | +2,64% | 8,89% | 384.200 |
| 22/02/2002 | 5,70 | 5,75 | 5,50 | 5,68 | -0,44% | 4,30% | 345.000 |
| 21/02/2002 | 5,71 | 5,85 | 5,69 | 5,71 | -1,21% | 2,89% | 444.200 |
| 20/02/2002 | 5,68 | 5,79 | 5,63 | 5,78 | +2,67% | 2,91% | 544.000 |
| 19/02/2002 | 5,66 | 5,72 | 5,58 | 5,63 | +0,45% | 2,39% | 442.200 |
| 15/02/2002 | 5,61 | 5,68 | 5,57 | 5,60 | -0,88% | 1,96% | 439.600 |
| 14/02/2002 | 5,67 | 5,75 | 5,58 | 5,65 | +0,00% | 3,00% | 628.400 |
| 13/02/2002 | 5,75 | 5,75 | 5,48 | 5,65 | -0,44% | 4,78% | 677.400 |
| 12/02/2002 | 5,53 | 5,77 | 5,48 | 5,68 | +2,25% | 5,33% | 1.189.200 |
| 11/02/2002 | 5,69 | 5,88 | 5,35 | 5,55 | +17,58% | 9,23% | 6.314.400 |
| 08/02/2002 | 4,57 | 4,75 | 4,46 | 4,72 | +2,05% | 6,46% | 837.000 |
| 07/02/2002 | 5,12 | 5,13 | 4,41 | 4,63 | -7,87% | 14,08% | 425.000 |
| 06/02/2002 | 5,10 | 5,22 | 5,01 | 5,02 | -0,79% | 4,22% | 429.000 |
| 05/02/2002 | 4,98 | 5,18 | 4,98 | 5,06 | +2,12% | 4,12% | 387.200 |
| 04/02/2002 | 5,03 | 5,07 | 4,85 | 4,96 | -0,40% | 4,38% | 472.400 |
| 01/02/2002 | 4,99 | 5,02 | 4,93 | 4,98 | +0,91% | 1,80% | 186.000 |
| 31/01/2002 | 4,74 | 5,05 | 4,73 | 4,93 | +3,35% | 6,86% | 347.800 |
| 30/01/2002 | 4,66 | 4,82 | 4,60 | 4,77 | +1,49% | 4,62% | 227.400 |
| 29/01/2002 | 4,75 | 4,75 | 4,55 | 4,70 | +0,00% | 4,21% | 103.400 |
| 28/01/2002 | 4,72 | 4,77 | 4,63 | 4,70 | +1,84% | 2,97% | 60.000 |
| 25/01/2002 | 4,59 | 4,64 | 4,54 | 4,62 | +1,43% | 2,18% | 38.400 |
| 24/01/2002 | 4,70 | 4,78 | 4,55 | 4,55 | -4,21% | 4,79% | 77.000 |
| 23/01/2002 | 4,60 | 4,78 | 4,60 | 4,75 | +3,26% | 3,91% | 124.200 |
| 22/01/2002 | 4,73 | 4,73 | 4,52 | 4,60 | -2,13% | 4,34% | 155.200 |
| 18/01/2002 | 4,63 | 4,72 | 4,57 | 4,70 | +0,53% | 3,14% | 174.600 |
| 17/01/2002 | 4,68 | 4,72 | 4,58 | 4,68 | -1,58% | 2,89% | 124.600 |
| 16/01/2002 | 4,68 | 4,77 | 4,63 | 4,75 | +0,96% | 2,99% | 111.000 |